Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company Name/Scheme BLS Pharmaceuticals Limited ACN/ARSN ACN 084 464 193 1. Details of substantial holders (1) Name Giga Orca Pte. Ltd. (UEN 202410209H) and Maio Dangi ACN/ARSN The holders became substantial...
Becoming a substantial holder
Filed with ASX · · 2 pages · English
Release
BLS Pharmaceuticals Limited on 6ix
Earlier from BLS Pharmaceuticals
- AGM Date and Director Nominations
- Application for quotation of securities - BLS
- Initial Director's Interest Notice
- Angus Walker Appointed Alternate Director to Edward Myer
- S&P DJI Announces September 2026 Quarterly Rebalance
Later from BLS Pharmaceuticals
- Ceasing to be a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- BLS Quarterly Activities Report September 2026 Revised
- Q1 FY2027 Quarterly Activities Update
- Notice of Annual General Meeting/Proxy Form
Follow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals